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R-Spondin2 Is a Secreted Activator
of Wnt/-Catenin Signaling
and Is Required for Xenopus Myogenesis
proteins and lipoprotein receptor-related proteins 5 and
6 (LRP5/6), which are members of the LDL receptor
superfamily (Wodarz and Nusse, 1998; He et al., 2004).
Wnts are not the only secreted factors able to activate
the -catenin pathway. Secreted Frizzled-related pro-
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Im Neuenheimer Feld 280 tein 1 can activate Wnt/-catenin signaling at low dose
while it inhibits at high dose (Uren et al., 2000). Dkk2, aD-69120 Heidelberg
Germany member of the Dickkopf family of secreted Wnt antago-
nists, binds and activates LRP6 (Wu et al., 2000; Mao and
Niehrs, 2003). However, in the presence of its coreceptor
Kremen, Dkk2 inhibits Wnt/-catenin signaling (Mao andSummary
Niehrs, 2003). Another LRP6 ligand, Wise, can also acti-
vate or inhibit Wnt signaling in a context-dependentWe have carried out a small pool expression screen
manner (Itasaki et al., 2003). Recently, a novel Frizzledfor modulators of the Wnt/-catenin pathway and
ligand, Norrin, has been identified, which activatesidentified Xenopus R-spondin2 (Rspo2) as a secreted
-catenin signaling specifically through Frizzled 4 (Xuactivator of this cascade. Rspo2 is coexpressed with
et al., 2004).and positively regulated by Wnt signals and synergizes
In this study, we show that R-spondin2 (Rspo2), awith Wnts to activate-catenin. Analyses of functional
gene of previously unknown function, is regulated byinteraction with components of the Wnt/-catenin
Wnts and directly activates Wnt/-catenin signaling.pathway suggest that Rspo2 functions extracellularly
Rspo2 is required for Wnt/-catenin signaling in HeLaat the level of receptor ligand interaction. In addition
cells and specifically for Wnt-dependent myogenesis into activating the Wnt/-catenin pathway, Rspo2 over-
Xenopus. The data indicate that Rspo2 represents aexpression blocks Activin, Nodal, and BMP4 signaling
secreted effector of the Wnt/-catenin pathway.in Xenopus, raising the possibility that it may nega-
tively regulate the TGF- pathway. Antisense Morpho-
lino experiments in Xenopus embryos and RNAi ex- Results
periments in HeLa cells reveal that Rspo2 is required
for Wnt/-catenin signaling. In Xenopus embryos de- Isolation of Xenopus R-spondin2
pleted of Rspo2, the muscle markers myoD and myf5 To isolate novel genes modulating Wnt/-catenin signal-
fail to be activated and later muscle development is ing, we carried out an expression screen in HEK293T
impaired. Thus, Rspo2 functions in a positive feedback cells by transfecting the Wnt-responsive reporter TOP-
loop to stimulate the Wnt/-catenin cascade. FLASH (Korinek et al., 1997) together with cDNA pools
from a Xenopus eye library. One pool was identified
which stimulated the reporter 7-fold (Figure 1A). A cDNAIntroduction
harboring the activity was isolated from this pool by
sib selection. Sequence analysis revealed that thisWnt/-catenin signaling is implicated in diverse pro-
cesses during embryonic patterning in all metazoa gene represents the Xenopus homolog of R-spon-
din2 (Supplemental Figures S1A–S1C at http://www.tested (Moon et al., 1997; Wodarz and Nusse, 1998).
During early Xenopus embryogenesis, the Wnt/-cate- developmentalcell.com/cgi/content/full/7/4/525/DC1/),
member of a recently identified gene family of unknownnin pathway is involved in axial patterning at two stages,
before and after midblastula transition (MBT), the onset function (Chen et al., 2002; Kamata et al., 2004). There
are four related members in this family, which we termof zygotic transcription (Moon et al., 1997). Zygotic acti-
vation of the pathway functions in antagonizing Spe- R-spondin1-4, respectively (Supplemental Figures S1A–
S1C). While there are a number of EST sequences show-mann’s head organizer (Niehrs, 2004) and in activating
myogenesis. In chick and mammals, the role of Wnt ing homology to R-spondin in other vertebrates, no ho-
mologs were found in Drosophila and C. elegans.signaling in muscle development is well established
(Cossu and Borello, 1999; Borycki and Emerson, 2000). Xenopus Rspo2 is predicted to encode a secreted
protein with 243 amino acids (mature protein) and anIn Xenopus, injection of plasmid DNA encoding Xwnt8
under the control of a CSKA promoter induces ectopic isoelectric point of 9.8. All R-spondins contain an
N-terminal signal peptide (SP), two furin-like domainsmyoD expression. Inhibition of Wnt signaling, e.g., by
dominant-negative Xwnt8 or frzb1, inhibits expression of (FU), one thrombospondin type1 domain (TSP1), and a
C-terminal low complexity region enriched with posi-the myogenic genes myf5 and myoD and blocks muscle
formation (Hoppler et al., 1996; Leyns et al., 1997). tively charged amino acids (C) (Figure 1F).
While Xenopus Rspo2 contains a predicted N-terminalWnt/-catenin signaling engages two transmembrane
receptor classes, Frizzled (Fz) type 7-transmembrane signal peptide, secreted protein is almost undetectable
in the medium of transiently transfected 293T cells.
Since the C terminus is enriched with basic amino acids,*Correspondence: niehrs@dkfz-heidelberg.de
which promotes cell surface retention (LaRochelle et1Present address: Centro Nacional de Investigaciones Oncolo´gicas,
Melchor Ferna´ndez Almagro, 3. E-28029 Madrid, Spain. al., 1991; Houck et al., 1992), we tested a C-terminally
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Figure 1. Rspo2 Promotes Wnt/-Catenin
Signaling
(A) Identification of Xenopus Rspo2 by ex-
pression screening. RLU, relative light units.
(B) The C terminus of Rspo2 mediates cell
surface retention. Myc-tagged Rspo2 (wt) or
Rspo2C (C) were transfected in 293T cells,
and cell lysate and medium were analyzed by
Western blot. Co, untransfected cells.
(C) Rspo2 activates Wnt/-catenin signaling.
TOPFLASH luciferase reporter assays were
carried out in 293T cells with the following
transfected DNAs: mouse Wnt1 (Wnt), 5 ng;
mouse frizzled8 (fz), 1 ng; Xenopus Rspo2
(Rspo2), 0.1, 0.3, 0.9, and 2.7 ng.
(D) Rspo2 enhances Wnt3A signaling. Mouse
Wnt3A, Xenopus Rspo2C (Rspo2C), or
mock-conditioned media were added to 293T
cells followed by TOPFLASH luciferase re-
porter assays.
(E) Rspo2 stabilizes -catenin. Top: 293T
cells were treated with Rspo2C, Wnt3A, or
mock-conditioned media for 1 or 4 hr as indi-
cated. Cytosolic fractions were subjected to
Western blot and probed for -catenin and
-tubulin (loading control). Bottom: Immuno-
histochemical staining of -catenin in SHEP
cells after 3 hr treatment with the conditioned
media indicated. Arrowheads indicate nu-
clear -catenin. The percentage of cells
showing the represented staining is 90%
(Co), 85% (Rspo2), 80% (Wnt3A), and 90%
(Wnt3A  Rspo2).
(F) Domain analysis of Rspo2. Top: schematic
drawing of Xenopus Rspo2 and deletion con-
structs. sp, signal peptide; FU1, 2, furin-like domains; TSP1, thrombospondin type1 domain; C, positively charged C terminus. Bottom:
TOPFLASH luciferase reporter assays were carried out in 293T cells with the indicated constructs. Equal protein production was confirmed
by Western blot (data not shown).
truncated protein. Rspo2C is effectively secreted into cytosolic accumulation of -catenin due to its stabi-
the medium from 293T cells (Figure 1B) and is function- lization (Moon et al., 1997; Wodarz and Nusse, 1998).
ally active (Figure 1F). Since all R-spondins share the Treatment of 293T cells with Wnt3A conditioned medium
basic C terminus and since there are no obvious ER or induces cytosolic -catenin after 1 hr, and while recom-
Golgi retention signals, this suggests that the proteins binant Rspo2C alone is not able to stabilize -catenin
are normally associated with the cell surface. during this interval, it strongly enhances activity of
Wnt3A to do so (Figure 1E, top). After 4 hr treatment,
both Wnt3A and Rspo2C conditioned media are ableR-spondins Promote Wnt/-Catenin
to induce -catenin accumulation to similar levels (Fig-Signaling in 293T Cells
ure 1E, top). -catenin is known to enter the nuclei inTransfected Xenopus Rspo2 stimulates the TOPFLASH
response to Wnt stimulation and activate gene expres-reporter in a dose-dependent manner in 293T cells (Fig-
sion together with Lef/Tcf transcription factors (Wodarzure 1C) but not the mutant reporter TOPFLASH (Korinek
and Nusse, 1998). Treatment of SHEP cells by eitheret al., 1997; data not shown). All tested members of the
Wnt3A or Rspo2C conditioned media weakly inducesRspo family (e.g., murine Rspo1-3, human Rspo2, 3)
-catenin nuclear localization, while cotreatment withshow equivalent effects (Supplemental Figure S2A and
Wnt3A and Rspo2C strongly enhances nuclear accu-data not shown).
mulation (Figure 1E, bottom).Rspo2 signaling is sensitive to the Wnt/-catenin
We conclude that R-spondins represent a family ofpathway inhibitors dominant-negative TCF (Molenaar et
secreted proteins capable promoting Wnt/-catenin sig-al., 1996), Axin (Zeng et al., 1997), and dickkopf1 (Glinka
naling.et al., 1998) (Supplemental Figure S2B). A synergistic
To functionally study its signaling domains, we cre-signaling effect is observed when Rspo2 is cotrans-
ated serial deletions of Xenopus Rspo2 (Figure 1F). Asfected with extracellular but not with intracellular com-
discussed, the basic C terminus can be removed withoutponents of the Wnt/-catenin pathway (Supplemental
loss of activity and this is also true for the TSP1 domainFigure S2C). The greatest cooperation is reproducibly
(Figure 1F). However, the furin-like domains are neces-seen between Rspo2 and Wnts, either using conditioned
sary for Wnt/-catenin signaling since deletion of eithermedia (Figure 1D) or following cotransfection (Supple-
the furin-1 or -2 domains abolishes the activity in re-mental Figure S2C).
A hallmark of Wnt/-catenin signaling activation is the porter assays (Figure 1F).
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shown). During gastrulation, strong expression is de-
tected in the marginal zone in both deep and superficial
layers but is excluded from the Spemann organizer (Fig-
ure 2B). At late gastrula stage, Rspo2 expression per-
sists in lateral plate mesoderm and becomes detectable
in the anterior neural plate (Figure 2C). At stage 15,
expression is seen in two longitudinal stripes along the
neural plate (future roof plate), in the anterior neural
plate, and in lateral and posterior mesoderm (Figure
2D). Expression of Rspo2 at tailbud stage (Figure 2F)
is restricted to several regions of the brain, including
diencephalon and midbrain-hindbrain boundary, pro-
nephros, and dorsal neural tube. Expression is also
detected in the dorsal- and ventral-most portions of
somites, the dorsal fin and the proctodeum. Rspo2 ex-
pression in the brain of late tadpoles is mainly restricted
to diencephalon, including the zona limitans intratha-
lamica (zli) (Figure 2H).
Xenopus Rspo3 expression is related to that of Rspo2.
It is first detected at gastrula stage (not shown) and in
neurulae is expressed in the anterior border of the neu-
ral plate and posterior mesoderm (Figure 2E). At tail-
bud stage, it is coexpressed with Rspo2 in the central
nervous system but shows additional expression in
branchial arches and the tailbud (Figure 2G).
In mouse, Rspo3 transcripts are detected by in situ
hybridization at day 7.5 in the primitive streak (Figure
2J) while expression of Rspo1 and 2 is not detectable. At
Figure 2. Expression Analysis of Xenopus and Mouse R-spondins day 9.5, Rspo1-3 show differential expression in various
(A) Rspo2 expression during Xenopus development at the indicated neural and mesodermal derivatives (Figures 2K–2M),
embryonic stages analyzed by RT-PCR. Histone H4 was used for mainly along dorsal neural tube (Rspo1 and 3 ), dien-
normalization. RT, minus reverse transcription control.
cephalon (Rspo1, 2, 3), somites (Rspo3), and tailbud(B–H) Xenopus whole-mount in situ hybridizations of the indicated
mesoderm (Rspo3). In limb buds all three genes showgenes.
prominent differential expression (Figure 2I), particularly(B) Stage 11 embryo, dorso-vegetal view; dbl, dorsal blastoporal lip.
(C) Stage 12 embryo, dorsal view with anterior up. An anterior neural in the morphogenetically active region such as the apical
expression domain is indicated by arrowhead. ectodermal ridge (AER) (Rspo2).
(D) Stage 15 embryo, dorsal view with anterior up.
(E) Stage 14 embryo, dorsal view with anterior up.
(F and G) Tailbud stage embryos; ba, branchial arches; cm, cranial
R-spondins Are Coexpressedmusculature; di, diencephalon; dnt, dorsal neural tube; mhb, mid-
with and Regulated by Wntsbrain-hindbrain boundary; ov, otic vesicle; pn, pronephros; pdm,
proctodeum; s, somites; tb, tailbud mesoderm. Inset in (F) shows a R-spondins not only show functional interaction with
transverse section at the level indicated by arrowhead, showing Wnt signaling, but also coexpression with Wnt genes in
expression in dorsal neural tube and in the dorsal- and ventral-most many regions during Xenopus and mouse embryonic
parts of the somites.
development. In gastrula mesoderm of both Xenopus(H) Dissected Xenopus tadpole brain (lateral view) showing expres-
and mouse, Rspo2 and 3 are coexpressed with XWnt8sion in diencephalons (di) and zona limitans intrathalamica (zli),
and mWnt3, respectively. Similarly, at later stages,where sonic hedgehog is expressed (inset). dt, vt, dorsal and ventral
thalamus, respectively; sc, spinal cord; tel, telencephalon. R-spondin family members are widely coexpressed with
(I–M) Mouse whole-mount in situ hybridizations of the indicated a number of Wnt genes, e.g., in midbrain-hindbrain
genes. boundary, dorsal neural tube, and limb bud and tail bud
(I) Limb buds of day 12.5 mouse embryos. AER, apical ectoder-
(Parr et al., 1993; Liu et al., 1999). A direct comparisonmal ridge.
between the expression patterns of Xenopus Rspo2 and(J) Day 7.5 mouse embryo showing Rspo3 expression in the primi-
tive streak. Wnt8 and Wnt3A shows a large overlap (Figure 3A).
(K–M) Day 9.5 mouse embryos. di, diencephalon; dnt, dorsal neural Indeed, Wnts are able to induce Rspo expression
tube; met, metencephalon; tel, telencephalon. since Xenopus embryos injected with pCS-Wnt8 or pCS-
-catenin DNA upregulate both Rspo2 and Rspo3 by
RT-PCR (Figure 3B). Likewise, embryos injected withExpression of R-spondin Genes
pCS-Wnt8 or pCS-Wnt3A DNA show ectopic Rspo2 ex-in Xenopus and Mouse Embryos
pression by in situ hybridization (Figures 3C–3E). TheIn Xenopus embryos, no maternal Rspo2 RNA is de-
results indicate that the observed coexpression is duetected by RT-PCR. Its zygotic expression starts at early
to regulation of R-spondins by Wnts. This is consistentgastrula stage and remains constant throughout neuru-
with the observation that Rspo1 expression is reducedlation and organogenesis (Figure 2A). By whole-mount
in dorsal spinal cord of Wnt1 or Wnt3A knockout mousein situ hybridization, weak expression of Rspo2 is ob-
served throughout the ectoderm of early gastrulae (not embryos (Kamata et al., 2004).
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Figure 3. Regulation of Xenopus R-spondins by Wnt Signaling
(A) Comparison of XRspo2, XWnt8, and XWnt3A expression pattern
in early neurula embryos by whole-mount in situ hybridization. Dor-
sal view, anterior up.
(B) Top: Diagram of experiment. 4-cell stage embryos were injected
with 50 pg pCS-ppl (preprolactin), pCS-XWnt8, or pCS--catenin
into each blastomere, and DMZs were dissected, cultured until stage
11 equivalent, and analyzed by RT-PCR. Bottom: RT-PCR analysis
of the indicated genes. RT, minus reverse transcription control.
(C–E) 4-cell stage embryos were injected with 50 pg pCS-Wnt8,
pCS-Wnt3A, or pCS-ppl into one blastomere and fixed at stage 11
Figure 4. Rspo2 Inhibits TGF- Signaling in Xenopusfor in situ hybridization with XRspo2.
(A) 4-cell stage embryos were injected animally with 100 pg Rspo2,
100 pg Xwnt8, or 200 pg -catenin mRNA in each blastomere. At
R-spondin2 Activates Neural Markers stage 8, animal caps were dissected, cultured until stage 18 equiva-
and Promotes Muscle Formation lent, and analyzed for expression of the indicated marker
When the Wnt/-catenin pathway is overactivated in genes. RT, minus reverse transcription control.
(B) 2-cell stage embryos were injected with 100 pg Rspo2 or prepro-Xenopus embryos, a variety of responses are observed:
lactin (ppl) mRNA in each blastomere. Note ectopic cement glands(1) mRNA injection of pathway activators typically in-
(arrowhead) and shortened body axis in Rspo2-injected embryo.duces secondary embryonic axes in whole embryos and
(C–J) Whole-mount in situ hybridizations of the indicated genes.
anterior neural markers in animal caps and whole em- 8-cell stage embryos were injected with 100 pg of Rspo2 or ppl
bryos (Baker et al., 1999); and (2) DNA injection of path- mRNAs as indicated into one animal blastomere. LacZ mRNA was
way activators driving expression after MBT posterio- coinjected as lineage tracer in all panels except (C), (G), and (H).
(C–H) Stage 15 neurulae in anterior view.rizes the central nervous system (CNS) (Niehrs, 2004).
(I and J) Stage 11 gastrulae in vegetal view, dorsal up.To test if Rspo2 is able to mimic any of these effects,
(K–N) 4-cell stage embryos were injected animally with indicatedwe microinjected synthetic mRNA in Xenopus embryos.
RNAs. At stage 8, animal caps were dissected, cultured until stageHowever, Rspo2 mRNA injection does not induce sec-
10 equivalent, and analyzed for expression of Xvent2 (K) or Xbra
ondary axes in whole embryos, and injection of pCS- (L–N). RT, minus reverse transcription control. Embryos injected
Rspo2 DNA does not posteriorize CNS, since heads are with 100 pg preprolactin (ppl) were used as control. Amounts of
normal sized, Otx2 expression is expanded, and en2 is mRNAs used: 100 pg Rspo2, 50 pg or 250 pg of BMP-4, 50 pg of
activin, 25 or 100 pg of Wnt8, 200 pg of -catenin, 50 or 100 pgunaffected (Figures 4D and 4H).
of Xnr1, 2 or 20 pg of FGF8.In animal caps, Rspo2 induces the panneural markers
(O) BMP responsive luciferase reporter assay in 293T cells. Concen-NCAM and N-tubulin and the anterior neural marker,
trations of plasmids were: BRE4-luc, 10 ng, BMP4, 10 ng, Wnt1, 5
Otx2, as do Xwnt8 and -catenin (Figure 4A). Neural ng, Rspo2, 5 ng.
marker induction occurs in the absence of muscle actin,
indicating that the neuralizing effect is direct. Similarly,
To further analyze the mRNA overexpression effectin whole embryos injected with Rspo2 mRNA, ectopic
of Rspo2 on BMP4, Activin, Nodal, and FGF signaling,cement glands and lateral expansion of the neural plate
we carried out animal cap assays and tested for theare observed at the injected side, as shown by expres-
induction of target genes by these growth factor signalssion of neural markers Sox3, Otx2, not2, en2, and Rx1
(Figures 4K–4N). Rspo2 expectedly blocks BMP4-medi-(Figures 4B–4H). Ectopic Otx2 expression is observed
already in gastrula stage embryos (Figures 4I and 4J). ated Xvent2 expression but surprisingly also inhibits
R-Spondin and Wnt Signaling
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Activin- and Nodal-mediated Xbra induction (Figures
4K–4M). This is unlike XWnt8 and -catenin mRNA injec-
tions, which do not affect Xbra induction by Activin (Fig-
ure 4L). In contrast to signaling by these TGF- type
growth factors, FGF8-induced Xbra expression is unaf-
fected by overexpressed Rspo2 (Figure 4N). To test if
BMP signaling is also affected in 293T cells, luciferase
reporter assays were carried out using BRE4-luc (Hata
et al., 2000). Neither Wnt1 nor Rspo2 have an effect
on BMP4-stimulated luciferase activity (Figure 4O). We
conclude that Rspo2 overexpression in addition to acti-
vating the Wnt/-catenin pathway is also able, in Xeno-
pus, to interfere with signaling by three TGF- family
growth factors.
Another well-known effect of zygotic Wnt/-catenin
signaling is its ability to promote myogenesis (Cossu and
Borello, 1999). For example, XWnt8 can induce muscle
formation in ventral mesodermal cells (Hoppler et al.,
1996). When ventral marginal zones (VMZs) from Rspo2-
injected embryos are dissected and cultured until stage
40, they elongate, form tail-like structures, and are con-
tractile. This phenotype is indistinguishable from control
lateral marginal zone explants (LMZs), which typically
differentiate muscle (Figures 5A and 5B). In situ hybrid-
ization confirmed induction of muscle actin in both
Wnt8- and Rspo2-injected VMZs but not in control (pre-
prolactin-injected) VMZs (Figure 5C). Since R-spondins
are able to enhance Wnt signaling in 293T cells, we
tested their cooperation in Xenopus myogenesis. Myf5
is a myogenic marker characteristically expressed in
lateral mesoderm (Dosch et al., 1997). However, it is
excluded from dorsal mesoderm, and dorsal marginal
zone (DMZ) explants express only little myf5 as deter-
mined by RT-PCR (Figure 5D). In DMZs from embryos
injected with DNA constructs driving post MBT expres-
sion, myf5 is weakly induced by Rspo2, moderately by
Wnt8, and strongly by their combination (Figure 5D, top).
The myogenesis-promoting effect of Rspo2 is repressed Figure 5. Rspo2 Promotes Myogenesis in Xenopus Embryos
by dominant-negative dishevelled (Xdd1), dkk1, and (A) Diagram of the experiments. 4-cell stage embryos were injected
with 50 pg plasmid DNA constructs in all blastomeres, and theGSK-3, which all block Wnt signaling (Figure 5D, bot-
indicated fragments were explanted at stage 10.5, cultured, andtom). In summary, the results suggest that Rspo2 can
processed for whole-mount in situ hybridization (C) or RT-PCR (D).promote myogenesis via the Wnt/-catenin pathway.
(B) Stage 40 equivalent VMZ or LMZ explants. Note tail-like struc-
tures in VMZs from Rspo2-injected embryos.
R-spondin2 Is Required for Wnt/-Catenin- (C) In situ hybridization of stage 25 VMZs for muscle actin.
(D) RT-PCR analysis for the indicated genes in stage 11 equivalentMediated Myogenesis
DMZ and stage 25 equivalent VMZ explants. Xdd1, dominant-nega-To investigate the physiological role of Rspo2 during
tive Xenopus dishevelled, Co, preprolactin.RT, minus reverse tran-Xenopus embryogenesis, we injected antisense mor-
scription control.
pholino oligonucleotides (Rspo2Mo). The ability of
Rspo2Mo to block Rspo2 protein production is demon-
strated by Western blot (Figure 6A). Injection of this undergo cell death (data not shown). At gastrula stage,
expression of the myogenic markers myf5 and myoD isMorpholino into one dorso-animal blastomere at 8-cell
stage results in eye defects, although the expression of strongly downregulated at the Rspo2Mo-injected side
(panels e–h), while the panmesodermal marker Xbra andearly eye (Rx1, Pax6), anterior neural (Otx2), and pan-
neural markers (Sox3) is not obviously affected (not the organizer marker Xnot2 are unaffected (panels i–l).
To test the specificity of Rspo2Mo, rescue experi-shown).
Equatorial injection of Rspo2Mo in one blastomere at ments were performed by coinjecting Rspo2Mo to-
gether with an Rspo2 RNA, in which six noncoding nu-8-cell stage leads to muscle defects at the injected side
(Figure 6B). In situ hybridization for muscle actin and cleotides were mutated so that it would not be targeted
by this morpholino. Expression of myf5 (Figure 6C) andtransverse trunk sections show that Rspo2Mo injection
causes disorganized somites (panels a and b) and re- myoD (data not shown) is effectively rescued by this
mutant Rspo2 RNA, indicating that the effect ofduced myotomes (panels c and d). Lineage tracing ex-
periments showed that Rspo2Mo-injected cells contrib- Rspo2Mo on myogenesis is specific.
We used Rspo2Mo as a tool to examine the epistaticute to lateral plate mesoderm instead of somites or
Developmental Cell
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Figure 6. Xenopus Rspo2 Is Required for
Muscle Formation
(A) Rspo2Mo specifically inhibits translation
of its cognate DNA. Top: Diagram of the ex-
periment. 2-cell stage Xenopus embryos
were injected with 100 pg Myc-tagged Rspo2
mRNA in the animal region, and at 8-cell
stage, the same embryos were then injected
with 5 ng of Rspo2Mo or CoMo in all animal
blastomeres, harvested at stage 11, and pro-
cessed for Western blot analysis of Myc-
tagged Rspo2 and -tubulin.
(B) Depletion of Rspo2 protein causes muscle
defects and downregulation of myogeneic
markers. 4-cell stage embryos were injected
equatorially into one blastomere with 5 ng
control morpholino oligonucleotides (CoMo)
or Rspo2Mo as indicated together with 50 pg
ppl mRNA or 50 pg LacZ RNA as lineage
tracer and analyzed at tailbud or gastrula
stage by in situ hybridization for the indicated
genes. In (a)–(f), double in situ hybridiza-
tion for gene of interest (dark blue) and for
ppl (red) was used. (a–d) Stage 25 embryos.
(a and b) Myotomes, visualized by muscle
actin expression, show malformations on
Rspo2Mo-injected side (b). (c and d) Trans-
versal section at the trunk level showing re-
duced muscle volume in (d). (e–h) myf5 and
myoD expression (dark blue) is downregu-
lated in the Rspo2Mo-injected region (red in
[e], [f] or light blue in [g], [h]). (i–l) Xbra and
Xnot2 expression (dark blue) is not affected in
the region of Rspo2Mo injections (light blue).
(C) Rspo2Mo act specifically. Rescue of myf5
reduction by coinjected Rspo2 mRNA. 4-cell
stage embryos were injected in one blasto-
mere with 5 ng of control morpholino (CoMo),
Rspo2Mo, 50 pg ppl mRNA, or 50 pg Rspo2
mRNA containing mismatches to Rspo2Mo.
Expression of myf5 was analyzed by in situ
hybridization at gastrula stage. The percent-
age of embryos with strongly affected (A),
moderately reduced (B), and normal (C) myf5
expression as displayed in the representative
embryos is indicated. Standard deviation was
calculated from three independent experi-
ments.
(D) Rspo2Mo blocks Wnt signaling upstream of dishevelled during muscle formation. 4-cell stage embryos were radially injected with 5 ng of
Rspo2Mo or CoMo, 50 pg pCS-XWnt8, pCS-dishevelled (Xdsh), pCS-dominant-negative GSK-3 (dnGSK), or pCS--catenin. At stage 10.5
DMZs (a) or VMZs (b) or LMZs (c and d) were explanted and cultured until stage 11 (a, c) or 25 (b, d) for RT-PCR analysis of the genes
indicated. RT: minus reverse transcription control.
position of Rspo in the Wnt/-catenin pathway. As read not receive Rspo2Mo. Taken together, these results indi-
cate that Rspo2 affects the Wnt/-catenin pathway atout for Wnt/-catenin signaling, we used the expression
of myf5 and muscle actin in marginal zone explants the level or upstream of dishevelled.
(Figure 6D). In DMZ and VMZ explants, Wnt8 DNA in-
duces myf5 and muscle actin, and this induction is sig- R-spondins Are Required for Wnt/-Catenin
nificantly blocked by Rspo2Mo (Figure 6D, panels a and Signaling in HeLa Cells
b, lanes 3 and 4). However, myf5 and muscle actin induc- We next investigated the requirement of Rspo2 for Wnt
tion by intracellular activators of the Wnt pathway like signaling in mammalian cells using siRNA. Since there
disheveled, dnGSK-3, and -catenin is unaffected by are four R-spondins with apparently redundant function,
Rspo2Mo (panels a and b, lanes 5–10). In LMZ explants, we selected HeLa cells, which only express Rspo3 and
Rspo2Mo injection downregulates endogenous myf5 very weakly Rspo2 (Figure 7A). Various other cell lines,
and muscle actin expression (Figure 6D, panels c and such as 293T cells, express all four genes, complicating
d, lanes 1 and 2). In DNA coinjections, this effect is a siRNA approach.
rescued effectively by -catenin but only poorly by siRNA mediated gene knockdown was carried out by
XWnt8 (lanes 3–6). The residual effect of XWnt8 is likely transfecting pSUPER constructs (Brummelkamp et al.,
2002) to produce siRNAs targeted against human Rspo2due to its non-cell-autonomous action on cells that did
R-Spondin and Wnt Signaling
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again consistent with Rspo2 acting at the level or up-
stream of dishevelled.
We conclude that in HeLa cells R-spondins are re-
quired for full Wnt/-catenin signaling.
Expression of R-spondin Genes in Tumors
Misregulation of Wnt/-catenin signaling is implicated
in tumorigenesis, e.g., colon cancer, breast cancer, and
melanoma (Bienz and Clevers, 2000). Since R-spondins
promote Wnt/-catenin signaling, they may also play a
role in tumorigenesis. We therefore analyzed expression
of Rspo1-4 in human tumor and corresponding normal
tissue from individual patients (Supplemental Figure S3).
HRspo1 is weakly expressed in adult organs. It shows
upregulation in ovary tumors from two patients and in
one stomach tumor sample. HRspo2 is expressed in
organs of endodermal origin, including colon, rectum,
small intestine, and lung. Its expression decreased in
corresponding tumor samples. HRspo3 is expressed
widely and decreases in many tumor samples. In gen-
eral, the expression of hRspo1-3 is deregulated in a
number of tumors, while hRspo4 expression is very weak
both in human adult organs and tumors (data not
shown).
Discussion
Rspo2 Is an Extracellular Activator
of Wnt/-Catenin Signaling
and Is Required for Myogenesis
We have identified Rspo2 as an activator of the Wnt/
-catenin pathway. To our knowledge, the only other
secreted activators of the pathway are Wnts themselves
as well as the recently described Fz4 ligand Norrin (Xu
et al., 2004). While Dkk2, sFrp1, and Wise are able to
activate the pathway as well when overexpressed, theyFigure 7. R-spondins Are Required for Wnt Signaling in HeLa Cells
also function as inhibitors and there is no evidence that
(A) RT-PCR analysis showing differential expression of human
the activation observed in in vitro assays is of physiologi-Rspo1-4 in HeLa and 293T cell lines. Actin was used for normal-
cal relevance (Uren et al., 2000; Wu et al., 2000; Itasakiization.
(B) Specificity of siRNAs. 293T cells were cotransfected with et al., 2003). Our results show that the activation of
pSUPER-Rspo2 or 3 (siRNA), FLAG-tagged Rspo3, and GFP (trans- Wnt/-catenin signaling by Rspo2 is of physiological
fection control). Expression of Rspo3 and GFP were analyzed by relevance during myogenesis and is also required for
Western blot. Wnt signaling in HeLa cells. Expression of the myogenic
(C and D) R-spondins are required for Wnt/-catenin signaling in
genes myf5 and myoD depends on Wnt/-catenin sig-HeLa cells. Wnt luciferase reporter assay in HeLa cells cotransfected
naling in Xenopus as well as in other vertebrateswith the indicated constructs. Wnt3A was added as conditioned
medium. RLU, relative light units. (Cossu and Borello, 1999). In mouse, signals from the
neural tube and dorsal ectoderm, which induce myf5
and myoD, respectively, can be mimicked by Wnt7a-and 3 (siRNA Rspo2,3). As control, a nonsense siRNA
expressing cells. Likewise, paraxial mesodermal cellswas used. To test the efficiency of siRNA, FLAG-tagged
cultivated in vitro express myf5 and myoD in responsehuman Rspo3 was cotransfected with siRNAs and its
to Wnt1 and Wnt7a, respectively (Tajbakhsh et al., 1998).production was repressed by siRNA Rspo3 but not
Furthermore, myf5 is repressed in Wnt1/Wnt3A doublesiRNA Rspo2 (Figure 7B).
mutant mice (Ikeya and Takada, 1998). In Xenopus, Wnt/In Wnt-reporter assays, both siRNA Rspo2 and 3 de-
-catenin signaling is required much earlier for myo-creased Wnt3A-induced luciferase activity compared to
genic gene expression than in mouse, since the expres-control siRNA (Figure 7C). When siRNA Rspo2 and 3 are
sion of myf5 and myoD is repressed/activated alreadycotransfected, reporter activity drops to 40%. This effect
at gastrula stage by various Wnt inhibitors/activatorsis specific since the decreased Wnt signaling can be
(Hoppler et al., 1996; Leyns et al., 1997; Marom et al.,rescued by cotransfected mouse Rspo2, which is not
1999). Indeed, myf5 is an immediate-early responsetargeted by siRNAs against human R-spondins (Figure
gene for zygotic Wnt/-catenin signaling at gastrula7C). Furthermore, unlike Wnt3A-induced reporter activ-
stage (Shi et al., 2002). Consistent with this, we observeity, siRNA Rspo23 do not affect Li-induced Wnt/
that Rspo2Mo depletion blocks myogenic gene expres--catenin signaling (Figure 7D). Since Li acts by inhib-
iting GSK-3 activity (Klein and Melton, 1996), this is sion at early gastrula stage.
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Rspo2 is coexpressed in a variety of tissues with Wnts possibility is that Rspo2 interacts with a very specific
Frizzled receptor we have not tested, similar to the Nor-and can be ectopically activated by Wnt signaling. Like-
wise, mouse Rspo1 expression is downregulated in rin-Fz4 interaction (Xu et al., 2004).
Supporting a complex mechanism of action is themouse Wnt1 and Wnt3A mutants (Kamata et al., 2004).
Therefore, Rspo2 may play a role in a positive feedback ability of Rspo2 to block signaling of Activin, Nodal, and
BMP4. While inhibition of BMP4 signaling and neuralloop of Wnt/-catenin signaling, similar to components
of other growth factor signaling pathways, e.g., BMP4, induction in animal caps may be accounted for by activa-
tion of the Wnt/-catenin pathway (Baker et al., 1999),Delta-Notch, and FGF8, which form synexpression
groups (Gawantka et al., 1998; Niehrs and Pollet, 1999). the effect on Activin, Nodal, and BMP suggests a general
TGF- inhibiting effect of Rspo2. In this respect, Rspo2Rspo2 protein is closely associated with the cell surface,
suggesting that it acts at short range, while vertebrate somewhat resembles CTGF and Cerberus, which affect
both the TGF- as well as the Wnt/-catenin pathwayWnt proteins can act at long range (Kiecker and Niehrs,
2001). This raises the possibility that Rspo2 plays a role (Piccolo et al., 1999; Abreu et al., 2002; Mercurio et al.,
2004). However, these overexpression effects of BMPin a local feedback to promote high levels of Wnt/
-catenin signaling in Wnt-expressing cells. and Activin inhibition by Rspo2 may not be physiologi-
cally relevant: (1) BMP signaling in 293T cells is unaf-In mouse, the expression of Rspo3 is very similar to
that of Xenopus Rspo2, suggesting that the two genes fected by Rspo2; (2) Rspo2 is coexpressed with both
Xbra (an Activin target) and Otx2 and Rx1 (negativeplay equivalent roles. However, mRspo1 and 2 also show
prominent expression in regions with active Wnt signal- BMP4 targets); and (3) our Morpholino data show neither
expansion of Xbra nor reduction of Otx2 or Rx1 (Figureing, including the midbrain-hindbrain boundary and roof
plate, and Rspo2 is coexpressed with Wnt3 in the apical 6B and data not shown), as would be expected if these
signals were under negative control of Rspo2.ectodermal ridge (Barrow et al., 2003). Although we have
focused on the functional analysis of Rspo2, we note
Experimental Proceduresthat the other members of the R-spondin family also
activate the Wnt-luciferase reporter (Supplemental Fig-
Isolation of R-spondins and Constructs
ure S2A and data not shown), suggesting that the whole A Xenopus adult eye cDNA library in pCS2 was used to prepare
family acts as Wnt modulator. pools of about 250 colonies. Plasmid DNA from each pool was
transiently transfected into 293T cells together with the Wnt receptor
frizzled8, the Wnt reporter TOPFLASH (Korinek et al., 1997) andMechanism of Rspo2 Action
pRL-TK (Promega) using FuGENE6 (Roche) transfection reagent.The evidence that Rspo2 is an effector of Wnt/-catenin
Luciferase assay was carried out 24 hr after transfection. A positive
signaling rests on the following findings: (1) Rspo2 is clone was isolated from the pool by sib selection. Human Rspo2
coexpressed with and induced by Wnts; (2) Rspo2 in- and 3 cDNAs were obtained from RZPD. Fragments of hRspo1 and
4 were RT-PCR amplified from mRNA of 293T cells and used asduces Wnt/-catenin signaling and strongly synergizes
hybridization probes. Full-length mouse Rspo1 and 2 were isolatedwith Wnt in this respect; (3) Rspo2 signaling is blocked
from a mouse embryonic day 13.5 cDNA library. The sequence ofby Wnt inhibitors; and (4) Rspo2 is required for Wnt/
X. tropicalis Rspo3 was obtained from Sanger Institute database
-catenin signaling in HeLa cells and in Xenopus. Finally,
and a cDNA fragment was cloned by RT-PCR from X. tropicalis
recombinant Rspo2Wnt3A synergistically stabilize embryos. C-terminally Myc- or FLAG-tagged constructs and all dele-
-catenin within 1 hr, suggesting that its effects on the tion constructs were created by PCR. Xenopus Rspo2C was cloned
by deleting the last 37 amino acids. The Rspo cDNAs were clonedpathway are direct.
in pCS2 and Bluescript vectors for use in gene expression and asThe results indicate that Rspo2 functions extracellu-
probes, respectively.larly at the level of receptor-ligand interaction during
Wnt/-catenin signaling: (1) Rspo2 is a secreted protein;
Cell Culture, Recombinant Proteins, and Luciferase
(2) it strongly synergizes with extracellular components Reporter Assays
of the Wnt pathway, including Wnts, Fz, and LRP5, 6, HEK293T, SHEP, and HeLa cell lines were maintained in DMEM,
10% FCS, and 10% CO2. Xenopus Rspo2C conditioned mediumbut not with the intracellular transducers, e.g., Dishev-
was produced by transient transfection in 293T cells. Mouse Wnt3Aelled or -catenin; (3) Rspo2 signaling is blocked by
conditioned medium was produced from mouse L cells stably trans-dkk1, Xdd1, and GSK-3; and (4) Wnt8/Wnt3A but not
fected with Wnt3A (ATCC#CRL-2647). Luciferase reporter assays inDishevelled or Li signaling is dependent on Rspo2.
293T cells were carried out in 96-well plates as described (Wu et
Rspo2 could either directly activate or derepress Wnt/ al., 2000). Luciferase reporter assays in HeLa cells were carried out
-catenin signaling. Obvious nodes of direct interaction in 24-well plates in triplicates using Lipofectamine Plus transfection
reagent (Invitrogen). Per well a total of 400 ng DNA were transfected,for Rspo2 in the Wnt pathway are Wnts, Dkks, Fz, and
including 80 ng 7lef-fos-Luc (Novak et al., 1998), 10 ng pRL-TK, 10LRPs. However, we failed to observe direct binding be-
ng mouse frizzled8, 2 ng mouse lef1, and 300 ng pSuper plasmidtween any of these proteins (Dkk1-3, Fz1-8, LRP5, 6)
DNAs. 3 days after transfection, either mouse Wnt3A conditionedand recombinant Rspo2. This suggests that its mecha-
medium or medium containing 30 mM LiCl was added to stimulate
nism of interaction with the Wnt/-catenin pathway is Wnt signaling. 24 hr later, luciferase activity was determined using
more complex and may involve an unknown cofactor, the Dual luciferase system (Promega).
which renders cells competent to react to Rspo2. Indi-
Embryos, Explants, In Situ Hybridization, and RNA Synthesisrect evidence for such a cofactor is that Rspo2 is not
In vitro fertilization, embryo culture, staging, microinjection, andgenerally required for Wnt/-catenin signaling, it neither
culture of Xenopus embryo explants were carried out as describedpromotes maternal Wnt/-catenin signaling to induce
(Gawantka et al., 1995). Double- and single-labeling whole-mount
secondary axes nor zygotic signaling to posteriorize em- in situ hybridization was carried out according to Bradley et al.
bryos (data not shown). This may be explained by differ- (1996). A PCR fragment of tropicalis Rspo3 cDNA was used for in
situ hybridization on Xenopus laevis embryos. Whole-mount in situential expression of such a Rspo2 cofactor. Another
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hybridization of mouse embryos was performed according to pre- signals modulate formation of the Xenopus cement gland. Develop-
ment 122, 2739–2750.viously described procedures (Koop et al., 1996).
Brummelkamp, T.R., Bernards, R., and Agami, R. (2002). A system
Morpholino Antisense Oligonucleotides for stable expression of short interfering RNAs in mammalian cells.
and siRNA Constructs Science 296, 550–553.
The 5 nucleotide sequence of an additional (pseudo-) allele for Chen, J.Z., Wang, S., Tang, R., Yang, Q.S., Zhao, E., Chao, Y., Ying,
Xenopus Rspo2 gene was obtained using 5 RACE (GeneRacer kit, K., Xie, Y., and Mao, Y.M. (2002). Cloning and identification of a
Invitrogen). Based on these sequences, an antisense morpholino cDNA that encodes a novel human protein with thrombospondin
oligonucleotide targeting both pseudoalleles around the ATG start type I repeat domain, hPWTSR. Mol. Biol. Rep. 29, 287–292.
codon was designed (Rspo2Mo): GCCGTCCAAATGCAGTTTCAAC.
Cossu, G., and Borello, U. (1999). Wnt signaling and the activation
pSuper constructs producing siRNA against human Rspo2,3 or a
of myogenesis in mammals. EMBO J. 18, 6867–6872.
nonsense control were made according to Brummelkamp et al.
Dosch, R., Gawantka, V., Delius, H., Blumenstock, C., and Niehrs,(2002). The sequences are: human Rspo2, TCCCATTTGCAAGGGT
C. (1997). Bmp-4 acts as a morphogen in dorsoventral mesodermTGT; human Rspo3, AGCTGACTGTGATACCTGT; nonsense control,
patterning in Xenopus. Development 124, 2325–2334.ACTACCGTTGTTATAGGTG.
Gawantka, V., Delius, H., Hirschfeld, K., Blumenstock, C., and Niehrs,
C. (1995). Antagonizing the Spemann organizer: role of the homeo-Immunohistochemistry, Western Blot, and Dot Blot Analysis
box gene Xvent-1. EMBO J. 14, 6268–6279.Immunohistochemistry to detect-catenin in SHEP cells was carried
Gawantka, V., Pollet, N., Delius, H., Pfister, R., Vingron, M., Nitsch,out according to Scheiffele et al. (1998) using anti--catenin anti-
R., Blumenstock, C., and Niehrs, C. (1998). Gene expression screen-body (Transduction Laboratories). For detection of tagged Rspo
ing in Xenopus identifies molecular pathways, predicts gene func-proteins or loading controls on Western blot, anti-Myc (clone 9E10),
tion and provides a global view of embryonic patterning. Mech. Dev.anti-FLAG (M2, SIGMA) monoclonal antibodies, chick anti-GFP
77, 95–141.(Chemicon), and mouse anti--tubulin (SIGMA) antibodies were
used. Chemiluminescence detection (SuperSignal solution, Pierce) Glinka, A., Wu, W., Onichtchouk, D., Blumenstock, C., and Niehrs,
was performed using anti-mouse IgG-HRP (Pierce). For Rspo ex- C. (1997). Head induction by simultaneous repression of Bmp and
pression analysis in tumor samples, the Cancer Profiling Array II Wnt signalling in Xenopus. Nature 389, 517–519.
(Clontech) was used. Glinka, A., Wu, W., Delius, H., Monaghan, A.P., Blumenstock, C.,
and Niehrs, C. (1998). Dickkopf-1 is a member of a new family of
RT-PCR secreted proteins and functions in head induction. Nature 391,
RT-PCR assays were carried out as described (Dosch et al., 1997; 357–362.
Glinka et al., 1997); additional primers were: Xenopus Rspo2 (for-
Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou,
ward, GAATGCCCAGAAGGATTTGC; reverse, GGGATGGTGTCTT
A., and Massague, J. (2000). OAZ uses distinct DNA- and protein-
TTGCTGG); Xenopus Rspo3 (forward, GAAGCAAATTGGAGTCTG
binding zinc fingers in separate BMP-Smad and Olf signaling path-
TCG; reverse, GATTGTTCTCAAACCCTTCAGG); human Rspo1 (for-
ways. Cell 100, 229–240.
ward, ACAGACACAAGACACACACGC; reverse, TGTCTTCTGGTGG
He, X., Semenov, M., Tamai, K., and Zeng, X. (2004). LDL receptor-CCTCAG); human Rspo2 (forward, CCGAGCCCCAGATATGAAC; re-
related proteins 5 and 6 in Wnt/{beta}-catenin signaling: arrows pointverse, TGACCAACTTCACATCCTTCC); human Rspo3 (forward, AGG
the way. Development 131, 1663–1677.GACTGAAACACGGGTC; reverse, TGTCTTCTGGTGGCCTCAG); hu-
Hoppler, S., Brown, J.D., and Moon, R.T. (1996). Expression of aman Rspo4 (forward, AAGCTGGGACACAGCACAG; reverse, GAAG
dominant-negative Wnt blocks induction of MyoD in Xenopus em-CCTTGGAGCCTTGTC).
bryos. Genes Dev. 10, 2805–2817.
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